CVS HEALTH CORPORATION (CVS) FY2025 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2025-06-30

Swipe to see the full flow
CVS HEALTH CORPORATION (CVS) FY2025 Q2 Balance SheetBalance sheet as of 2025-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$94.16 BCurrent assets$75.65 BLiabilities$180.79 BAssets$258.34 BNon-current liabilities$86.63 BNon-current assets$182.69 BEquity$77.55 BGross equity(calculated)$114.40 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSAccounts receivable, netInventoriesCash and cash equivalentsOther current assetsInvestmentsGoodwillLong-term investmentsIntangible assets, netOperating lease right-of-use assetsProperty and equipment, netOther assetsSeparate accounts assetsPharmacy claims and discounts payableAccrued expenses and other current liabilitiesAccounts payableHealth care costs payableCurrent portion of long-term debtShort-term debtCurrent portion of operating lease liabilitiesOther insurance liabilitiesLong-term debtLong-term operating lease liabilitiesOther long-term liabilitiesOther long-term insurance liabilitiesDeferred income taxesSeparate accounts liabilitiesRetained earningsCommon stock, par value $0.01: 3,200 shares authorized; 1,785 shares issued and 1,267 shares outstanding at June 30, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplusAccumulated other comprehensive income (loss)Noncontrolling interestsCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Treasury stock, at cost: 518 shares at June 30, 2025 and December 31, 2024Pharmacy claims and discounts payablePharmacy claims and discounts payable$26.34 BAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$23.10 BCurrent liabilitiesCurrent liabilities$94.16 BAccounts payableAccounts payable$17.26 BHealth care costs payableHealth care costs payable$15.27 BAccounts receivable, netAccounts receivable, net$40.65 BCurrent assetsCurrent assets$75.65 BCurrent portion of long-term debtCurrent portion of long-term debt$6.16 BLiabilitiesLiabilities$180.79 BInventoriesInventories$17.45 BShort-term debtShort-term debt$3.04 BCash and cash equivalentsCash and cash equivalents$11.79 BAssetsAssets$258.34 BCurrent portion of operating lease liabilitiesCurrent portion of operating lease liabilities$1.91 BOther current assetsOther current assets$3.38 BOther insurance liabilitiesOther insurance liabilities$1.09 BInvestmentsInvestments$2.39 BLong-term debtLong-term debt$57.29 BNon-current liabilitiesNon-current liabilities$86.63 BNon-current assetsNon-current assets$182.69 BGoodwillGoodwill$91.20 BLong-term operating lease liabilitiesLong-term operating lease liabilities$14.33 BOther long-term liabilitiesOther long-term liabilities$4.78 BLong-term investmentsLong-term investments$29.86 BEquityEquity$77.55 BOther long-term insurance liabilitiesOther long-term insurance liabilities$4.77 BIntangible assets, netIntangible assets, net$26.22 BDeferred income taxesDeferred income taxes$3.60 BOperating lease right-of-use assetsOperating lease right-of-use assets$15.51 BSeparate accounts liabilitiesSeparate accounts liabilities$1.86 BProperty and equipment, netProperty and equipment, net$12.83 BGross equity (calculated)Gross equity(calculated)$114.40 BRetained earningsRetained earnings$63.94 BOther assetsOther assets$5.21 BSeparate accounts assetsSeparate accounts assets$1.86 BCommon stock, par value $0.01: 3,200 shares authorized; 1,785 shares issued and 1,267 shares outstanding at June 30, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplusCommon stock and capital surplus$50.02 BAccumulated other comprehensive income (loss)Accumulated other comprehensive income (loss)$272.00 MNoncontrolling interestsNoncontrolling interests$172.00 MTreasury stock, at cost: 518 shares at June 30, 2025 and December 31, 2024Treasury stock−$36.85 B
Chart details

CVS HEALTH CORPORATION (CVS) FY2025 Q2 Balance Sheet

Balance sheet as of 2025-06-30. The chart shows assets, liabilities and equity at that date.

Assets
258,343,000,000 US dollars
Current assets
75,649,000,000 US dollars
Non-current assets
182,694,000,000 US dollars
Liabilities
180,792,000,000 US dollars
Current liabilities
94,162,000,000 US dollars
Non-current liabilities
86,630,000,000 US dollars
Equity
77,551,000,000 US dollars
Noncontrolling interest
172,000,000 US dollars. Included in consolidated equity; this amount is not added again.
Accounts receivable, net
40,651,000,000 US dollars
Inventories
17,447,000,000 US dollars
Cash and cash equivalents
11,787,000,000 US dollars
Other current assets
3,378,000,000 US dollars
Investments
2,386,000,000 US dollars
Goodwill
91,203,000,000 US dollars
Long-term investments
29,858,000,000 US dollars
Intangible assets, net
26,224,000,000 US dollars
Operating lease right-of-use assets
15,512,000,000 US dollars
Property and equipment, net
12,825,000,000 US dollars
Other assets
5,214,000,000 US dollars
Separate accounts assets
1,858,000,000 US dollars
Pharmacy claims and discounts payable
26,338,000,000 US dollars
Accrued expenses and other current liabilities
23,101,000,000 US dollars
Accounts payable
17,258,000,000 US dollars
Health care costs payable
15,271,000,000 US dollars
Current portion of long-term debt
6,160,000,000 US dollars
Short-term debt
3,040,000,000 US dollars
Current portion of operating lease liabilities
1,906,000,000 US dollars
Other insurance liabilities
1,088,000,000 US dollars
Long-term debt
57,290,000,000 US dollars
Long-term operating lease liabilities
14,328,000,000 US dollars
Other long-term liabilities
4,782,000,000 US dollars
Other long-term insurance liabilities
4,769,000,000 US dollars
Deferred income taxes
3,603,000,000 US dollars
Separate accounts liabilities
1,858,000,000 US dollars
Retained earnings
63,936,000,000 US dollars
Common stock, par value $0.01: 3,200 shares authorized; 1,785 shares issued and 1,267 shares outstanding at June 30, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus
50,020,000,000 US dollars
Accumulated other comprehensive income (loss)
272,000,000 US dollars
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding
0 US dollars
Noncontrolling interests
172,000,000 US dollars
Treasury stock, at cost: 518 shares at June 30, 2025 and December 31, 2024
negative 36,849,000,000 US dollars
Gross equity (calculated)
114,400,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
CVS HEALTH CORPORATION (CVS) FY2025 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!